Siemens Healthineers AG (ETR:SHL)
Germany · Delayed Price · Currency is EUR | Market Cap | 55.11B |
| Revenue (ttm) | 23.38B |
| Net Income (ttm) | 2.17B |
| Shares Out | 1.11B |
| EPS (ttm) | 1.93 |
| PE Ratio | 25.67 |
| Forward PE | 20.32 |
| Dividend | 0.95 (1.92%) |
| Ex-Dividend Date | Feb 19, 2025 |
| Volume | 534,593 |
| Average Volume | 686,956 |
| Open | 49.49 |
| Previous Close | 49.36 |
| Day's Range | 49.33 - 49.71 |
| 52-Week Range | 41.21 - 58.48 |
| Beta | 0.75 |
| RSI | 65.57 |
| Earnings Date | Nov 5, 2025 |
About Siemens Healthineers AG
Siemens Healthineers AG, through its subsidiaries, develops, manufactures, and sells a range of diagnostic and therapeutic products and services to healthcare providers worldwide. It operates through four segments: Imaging, Diagnostics, Varian, and Advanced Therapies. The Imaging segment provides magnetic resonance imaging, computed tomography, X-ray systems, molecular imaging, and ultrasound systems. Its Diagnostics segment offers in-vitro diagnostic products and services to healthcare providers in laboratory and point-of-care diagnostics; and... [Read more]
Financial Performance
In 2024, Siemens Healthineers AG's revenue was 22.36 billion, an increase of 3.15% compared to the previous year's 21.68 billion. Earnings were 1.94 billion, an increase of 28.69%.
Financial StatementsNews
Siemens evaluating spinoff of stake in Siemens Healthineers - report
Siemens Healthineers AG: Q4 ‘25 and FY26 expected to be burdened by headwinds.
Siemens Healthineers AG’s (SHL) ended its FY25 yesterday. Looking back, SHL delivered a solid 9M FY25 (+6.4% yoy, reported EBIT margin 13.3%) and raised guidance to 5.5–6.0% revenue growth and adj. EP...
New Drug Testing Analyzer from Siemens Healthineers Raises the Bar for Court, Military, and Forensics Testing, Offering Clinical-Quality Results
TARRYTOWN, N.Y.--(BUSINESS WIRE)-- #drugtesting--New drug testing analyzer helps identify substance use, monitor therapeutic and immunosuppressant drugs, and perform serum toxicology testing.
Siemens Healthineers AG (SMMNY) Pre-Close For Q4 FY2025 (Transcript)
Siemens Healthineers AG - Special Call
Siemens Healthineers AG - Special Call Company Participants Presentation Unknown Executive Welcome to our pre-close catch-up for Q4 fiscal year 2025, which was recorded on September 25, 2025. In this ...
European Stocks Open Lower; H&M Surges, Siemens Healthineers (SHL) Falls
European Stocks Open Lower; H&M Surges, Siemens Healthineers (SHL) Falls
VedaBio Announces Strategic Agreement with Siemens Healthineers and Series A Extension, Totaling Up to $25 Million
SAN DIEGO--(BUSINESS WIRE)--VedaBio, a pioneering biotechnology company transforming molecular detection, today announced a Series A extension alongside a strategic agreement with Siemens Healthineers...
SYK Partners With Siemens Healthineers to Boost Stroke, Aneurysm Care
Stryker teams with Siemens Healthineers to develop a robotic ecosystem aimed at advancing stroke and aneurysm care.
EQS-CMS: Siemens Healthineers AG: Release of a capital market information
EQS Post-admission Duties announcement: Siemens Healthineers AG / Disclosure pursuant to Art. 5 para. 1 lit. b), para. 3 of the Regulation (EU) No. 596/2014, as last amended by Regulation (EU) No. 202...
Deal Dispatch: White House Mute On TikTok, BBVA's $18 Billion Takeover Offer Rejected
New On The Block Siemens Healthineers is chatting with major private equity firms about a potential sale of its diagnostics business. According to Bloomberg, Blackstone , CVC , KKR , and Montagu are i...
EVIDENT and Siemens Healthineers Join Efforts to Advance Digital Pathology at Klinikum Ludwigshafen
Collaboration combines AI imaging, diagnostics expertise, and clinical leadership to drive digital pathology forward Collaboration combines AI imaging, diagnostics expertise, and clinical leadership t...
Carna Health and Siemens Healthineers join forces to Advance Kidney Care Innovation
BOSTON--(BUSINESS WIRE)--Carna Health, a digital health company revolutionizing kidney care, announced a strategic agreement with Siemens Healthineers to accelerate adoption of Carna's AI-enabled chro...
EQS-CMS: Siemens Healthineers AG: Release of a capital market information
EQS Post-admission Duties announcement: Siemens Healthineers AG / Disclosure pursuant to Art. 5 para. 1 lit. b), para. 3 of the Regulation (EU) No. 596/2014, as last amended by Regulation (EU) No. 202...
EQS-DD: Siemens Healthineers AG: Dr. Bernhard Montag, buy
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them 01.08.2025 / 16:44 CET/CEST The issuer is solely responsi...
EQS-DD: Siemens Healthineers AG: Elisabeth Staudinger-Leibrecht, Program-based order to sell a portion of 223 Siemens Healthineers shares to cover tax and contribution obligations on share ...
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them 31.07.2025 / 17:55 CET/CEST The issuer is solely responsi...
EQS-DD: Siemens Healthineers AG: Elisabeth Staudinger-Leibrecht, Entitlement to transfer 223 Siemens Healthineers shares in connection with a Siemens Healthineers Share Program (transfer with ...
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them 31.07.2025 / 17:45 CET/CEST The issuer is solely responsi...
Siemens reduces stake in Siemens Healthineers to 71.12%
Siemens AG reduced its stake in medical technology company Siemens Healthineers by nearly 2 percentage points to 71.12%, according to a regulatory filing.
Siemens Healthineers AG 2025 Q3 - Results - Earnings Call Presentation
Siemens Healthineers AG (SEMHF) Q3 2025 Earnings Call Transcript
Siemens Healthineers reports Q3 results
'Trade barriers bad for the patients': Siemens Healthineers CEO
Siemens Healthineers CEO Bernd Montag warns EU-U.S. trade barriers are driving up healthcare costs, as company releases its Q2 earnings report.
Siemens Healthineers meets Q3 sales expectations, raises guidance
German medical technology company Siemens Healthineers on Wednesday reported third-quarter revenue slightly above analysts' consensus, citing strong growth in its China business after declines last ye...
EQS-CMS: Correction of a release from 28/07/2025, 18:00 CET/CEST - Siemens Healthineers AG: Release of a capital market information
EQS Post-admission Duties announcement: Siemens Healthineers AG / Disclosure pursuant to Art. 5 para. 1 lit. b), para. 3 of the Regulation (EU) No. 596/2014, as last amended by Regulation (EU) No. 202...
Siemens Healthineers: More Upside Is Possible
Siemens Healthineers Sets New Sustainability Benchmark as First IVD Manufacturer to Earn My Green Lab ACT Ecolabel for Analyzers, Reagents
TARRYTOWN, N.Y.--(BUSINESS WIRE)-- #healthcaredistribution--Siemens Healthineers has earned My Green Lab ACT Ecolabel Certification for more than 150 reagents used by medical laboratories for patient ...